A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
Clinical trial NCT04573192 · UNKNOWN
Trial details
- NCT number
- NCT04573192
- Sponsor
- Philogen S.p.A.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-19
- Primary completion
- 2025-03-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.